Last quarter (Q2 2023), TheWorks.co.uk plc's total revenue was £―, a decrease of ― from the same quarter last year. In Q2, TheWorks.co.uk plc's net income was £―. See TheWorks.co.uk plc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Apr 23	May 22	Apr 22	Apr 21	Apr 20
Total Revenue	-	£ 280.10M	£ 264.63M	£ 264.63M	£ 180.68M	£ 225.04M
Cost of Revenue	-	£ 236.20M	£ 216.05M	£ 216.05M	£ 159.76M	£ 193.65M
Gross Profit	-	£ 43.90M	£ 48.58M	£ 48.58M	£ 20.92M	£ 31.39M
Operating Expense	-	£ 33.93M	£ 33.13M	£ 33.13M	£ 19.83M	£ 28.63M
Operating Income	-	£ 9.97M	£ 15.45M	£ 15.45M	£ 1.09M	£ 2.77M
Net Non Operating Interest Income Expense	-	£ -4.42M	£ -5.18M	£ -5.18M	£ -5.47M	£ -4.45M
Other Income Expense	-	£ 155.00K	£ 111.00K	-	-	-
Pretax Income	-	£ 5.01M	£ 10.16M	£ 10.16M	£ -2.80M	£ -17.97M
Tax Provision	-	£ -265.00K	£ 1.44M	£ 1.44M	£ -502.00K	£ -270.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	£ 5.27M	£ 8.72M	£ 8.72M	£ -2.30M	£ -17.70M
Basic EPS	-	£ 0.08	£ 0.14	£ 0.14	£ -0.04	£ -0.28
Diluted EPS	-	£ 0.08	£ 0.14	£ 0.14	£ -0.04	£ -0.28
Basic Average Shares	-	£ 62.50M	£ 62.50M	£ 62.50M	£ 62.50M	£ 62.50M
Diluted Average Shares	-	£ 63.12M	£ 63.44M	£ 63.44M	£ 62.50M	£ 62.50M
Dividend Per Share	-	£ 0.02	£ 0.02	£ 0.00	£ 0.00	£ 0.04
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	£ 0.14	£ -0.05	£ 0.03
Reported Normalized Diluted E P S	-	-	-	£ 0.14	£ -0.05	£ 0.03
Rent Expense Supplemental	-	-	-	£ 1.94M	£ 831.00K	£ 2.55M
Total Expenses	-	£ 270.13M	-	£ 249.19M	£ 179.59M	£ 222.27M
Net Income From Continuing And Discontinued Operation	-	£ 5.27M	£ 8.72M	£ 8.72M	£ -2.30M	£ -17.70M
Normalized Income	-	£ 4.90M	-	£ 8.82M	£ -3.58M	£ 14.53M
Interest Expense	-	-	-	£ 5.19M	£ 5.49M	£ 4.47M
EBIT	-	£ 9.65M	£ 15.33M	£ 15.35M	£ 2.69M	£ -13.51M
EBITDA	-	£ 29.83M	-	£ 41.19M	£ 32.13M	£ 16.06M

Currency in GBP

TheWorks.co.uk plc Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing